Vulnerability Details : CVE-2023-41751
Sensitive information disclosure due to improper token expiration validation. The following products are affected: Acronis Agent (Windows) before build 32047.
Vulnerability category: BypassGain privilege
Products affected by CVE-2023-41751
- cpe:2.3:a:acronis:agent:*:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2023-41751
0.04%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 7 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2023-41751
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
6.3
|
MEDIUM | CVSS:3.0/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N |
1.0
|
5.2
|
Acronis International GmbH | |
|
5.5
|
MEDIUM | CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N |
1.8
|
3.6
|
NIST |
CWE ids for CVE-2023-41751
-
When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct.Assigned by:
- nvd@nist.gov (Primary)
- security@acronis.com (Secondary)
References for CVE-2023-41751
-
https://security-advisory.acronis.com/advisories/SEC-5615
Sensitive information disclosure due to improper token expiration validation - SEC-5615 - Acronis Advisory Database - AcronisVendor Advisory
Jump to